INTRODUCTION
============

Visualization of a protein of interest in living cells is becoming increasingly important, not only to precisely address cellular functions of the individual target protein, but also to understand the complicated biological system as a whole ([@b21-molce-42-386]; [@b41-molce-42-386]; [@b58-molce-42-386]; [@b85-molce-42-386]). In particular, recent rapid advances in live-cell imaging techniques, including nanoscopy and super-resolution microscopy (SRM), have augmented our ability to address the cellular functions of biomolecules at the nanoscale level (10--30 nm) ([@b79-molce-42-386]; [@b93-molce-42-386]). Numerous dyes and tag-labeling approaches have been developed for efficiently visualizing cellular target proteins ([@b21-molce-42-386]). Fusion of fluorescent protein tags has been used routinely owing to its ease and simplicity ([@b81-molce-42-386]). In addition, diverse self-labeling enzymes, such as Halo-tag ([@b59-molce-42-386]), SNAP-tag ([@b40-molce-42-386]) and CLIP-tag ([@b30-molce-42-386]), have also been explored for labeling target proteins using chemical fluorescent probes, which usually exhibit better photophysical properties than fluorescent proteins ([@b97-molce-42-386]). However, such protein-based tagging methods suffer from intrinsic limitations. Fused proteins or enzymes can only be added to N- or C-termini of the target protein ([@b21-molce-42-386]; [@b95-molce-42-386]). More critically, they can perturb the cellular function of the target protein, such as localization, activity or protein-protein interaction, owing to their relatively large size (\> 20 kDa) and tendency to form multimeric structures ([@b75-molce-42-386]; [@b98-molce-42-386]).

Attempts to reduce the size of the tagging unit have given rise to the development of various peptide-based approaches. For example, phage display of peptide libraries has led to isolation of the 12-residue peptide tags, S6 and A1, which enable orthogonal protein labeling catalyzed by the phosphopantetheinyl transferases, Sfp and AcpS, respectively ([@b108-molce-42-386]). A tetracysteine-based labeling scheme uses an even smaller peptide, a 6-amino acid motif (CCXXCC), that selectively binds to fluorescein arsenical hairpin (FlAsH) ([@b1-molce-42-386]). Such peptide-tag labeling methods, despite certain favorable characteristics, still suffer from critical problems, including high background and cellular toxicity of the organic fluorophores. Strictly speaking, peptide-based methods are not site-specific, since they do not allow residue-specific protein labeling ([@b21-molce-42-386]; [@b28-molce-42-386]; [@b60-molce-42-386]). On the other hand, the genetic incorporation of unnatural amino acid (UAA) approach using an engineered orthogonal aminoacyl-tRNA synthetase (AARS) and tRNA pair can ideally lead to site-specific protein labeling with minimal perturbations, since this method allows installation of special chemical groups into the desired residue of the target protein ([@b18-molce-42-386]; [@b47-molce-42-386]; [@b75-molce-42-386]). Details of UAA-enabled approaches and diverse labeling schemes have been summarized by some excellent reviews ([@b46-molce-42-386]; [@b57-molce-42-386]; [@b70-molce-42-386]; [@b83-molce-42-386]; [@b104-molce-42-386]). In this review, we briefly discuss recent progress in UAA-based site-specific protein labeling methods and their promising applications. UAAs described in this report are listed in [Figure 1](#f1-molce-42-386){ref-type="fig"} and [Table 1](#t1-molce-42-386){ref-type="table"}.

EXPANDING THE GENETIC CODE BEYOND NATURE'S REPERTOIRE
=====================================================

In addition to the standard 20 amino acids, biological systems have evolved to genetically encode two additional amino acids, selenocysteine (Sec) and pyrrolysine (Pyl), and incorporate them into proteins ([@b4-molce-42-386]). These two amino acids are thus sometimes referred to as the 21st and 22nd amino acids. In the case of Sec, serine is first attached to selenocysteinyl tRNA by SerRS ([@b52-molce-42-386]), and then converted into Sec by the sequential action of phosphoseryl-tRNA kinase (PSTK) ([@b14-molce-42-386]) and Sep (O-phosphoserine) tRNA:Sec tRNA synthase (SepSecS) ([@b106-molce-42-386]). Sec is then co-translationally inserted into proteins at a TGA stop codon with the help of special elongation factor (SelB) and a stem-loop Sec insertion sequence element (SECIS) ([@b29-molce-42-386]). Pyl is directly attached to pyrrolysyl tRNA (tRNA^pyl^) by pyrrolysyl-tRNA synthetase (PylRS) and incorporated into proteins at a TAG stop codon ([@b8-molce-42-386]; [@b74-molce-42-386]). Inspired by this natural expansion of the genetic code, researchers have developed a site-specific UAA incorporation technique (also called genetic code expansion) for reprogramming the universal genetic code by redesigning and evolving pairs of AARS and their cognate tRNAs ([@b65-molce-42-386]). The discovery of the PylRS/tRNA^pyl^ pair in methanogenic archaea, in particular, has helped rapidly advance this field ([@b99-molce-42-386]). PylRS/tRNA^pyl^ is a naturally occurring orthogonal pair that functions efficiently in diverse living organisms from bacteria ([@b8-molce-42-386]) and yeast ([@b33-molce-42-386]) to mice ([@b32-molce-42-386]). PylRS has a flexible amino acid binding pocket that is easily modified to accommodate a wide range of UAAs with diverse chemical structures. In addition, PylRS does not recognize the anticodon of tRNA^pyl^, thus enabling suppression of three different stop codons, TAG, TGA and TAA, without sacrificing PylRS/tRNA^pyl^ interactions ([@b89-molce-42-386]; [@b99-molce-42-386]).

DIRECT INCORPORATION OF FLUORESCENT UAAs
========================================

The major strength of the UAA incorporation technique is its ability to allow direct addition of a designed UAA into a specific position in a protein of interest. Researchers have explored this site-specific protein-labeling advantage by undertaking efforts to directly incorporate UAAs bearing various fluorescent chemical groups. The fluorescent UAA, 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (Anap) ([@b18-molce-42-386]; [@b51-molce-42-386]), was designed based on 6-propionyl-2-(N,N-dimethyl)aminonaphthalene (Prodan), a fluorophore that has been widely used in cell imaging ([@b102-molce-42-386]). For genetic incorporation of Anap in mammalian cells, the Anap-specific AARS, AnapRS, was developed from *Escherichia coli* leucyl-tRNA synthetase (LeuRS) ([@b18-molce-42-386]). Multiple mutations (L38F, M40G, L41P, Y499V, Y500L, Y527A, H537E, L538S, F541C, and A560V) were introduced into the amino acid-binding pocket of LeuRS through directed evolution to accommodate the large hydrophobic fluorescent UAA. Using the resulting Anap site-specific incorporation system, researchers demonstrated subcellular localization of target proteins to the nucleus or endoplasmic reticulum in mammalian cells ([@b18-molce-42-386]). Another fluorescent UAA is the coumarin derivative, (S)-1-carboxy-3-(7-hydroxy-2-oxo-2*H*-chromen-4-yl)propan-1-aminium (CouAA) ([@b16-molce-42-386]; [@b17-molce-42-386]; [@b100-molce-42-386]). A CouAA-specific synthetase was evolved from *Methanococcus jannaschii* tyrosyl-tRNA synthetase (TyrRS) through incorporation of eight mutations, Y32E, L65H, A67G, H70G, F108Y, Q109H, D158G, and L162G ([@b100-molce-42-386]). This CouAA incorporation system was successfully used to visualize the molecular chaperone, GroEL ([@b17-molce-42-386]), and the bacterial tubulin, FtsZ ([@b16-molce-42-386]), without affecting their cellular functions. 2-Amino-3-(5-\[dimethylamino\]naphthalene-1-sulfonamide) propanoic acid is a fluorescent UAA derived from the dansyl group, and is thus also called dansylalanine ([@b88-molce-42-386]). A dansylalanine-specific synthetase containing seven mutations (M40A, L41N, T252A, S497C, Y499I, Y527G, and H537T), was engineered from *E. coli* LeuRS, exhibiting relatively low protein production yield (0.29 mg/L culture) in yeast ([@b88-molce-42-386]).

Ideally, direct genetic incorporation of fluorescent UAAs would minimize possible functional disruptions caused by fluorescence tagging. This method can also minimize the distance between the fluorophore and the protein of interest, which is essential for super-resolution imaging ([@b46-molce-42-386]). However, on a discouraging note, there are some concerns regarding the direct incorporation of fluorescent UAAs that impede their widespread use in cell biology ([@b46-molce-42-386]). Developing a specialized binding pocket in an orthogonal AARS for the unusually bulky chemical structures of fluorescent UAAs is quite difficult ([@b12-molce-42-386]). In addition, the incorporation efficiency of intrinsically fluorescent UAAs is considerably lower than that of UAAs designed for attachment of a fluorescent group, listed below ([@b88-molce-42-386]). Furthermore, most genetically incorporated fluorescent UAAs suffer from low quantum yield ([@b88-molce-42-386]). For example, CouAA has a quantum yield of 0.63 ([@b100-molce-42-386]), which is comparable to that of enhanced green fluorescent protein (EGFP) ([@b95-molce-42-386]), whereas the quantum yield of Anap, at 0.48 ([@b18-molce-42-386]), is even lower. Such unfavorable characteristics of direct fluorescent UAA incorporation systems have limited their use in biological systems and live-cell visualization.

BIOORTHOGONAL CONJUGATION SCHEMES
=================================

An alternative to directly incorporating fluorescent UAAs that has been widely attempted is bio-conjugation--mediated fluorescent tagging. For this, UAAs that enable bioorthogonal reactions need to be incorporated into proteins and then conjugated with specially designed dyes to achieve site-specific fluorescence labeling of the protein of interest ([@b45-molce-42-386]; [@b55-molce-42-386]; [@b62-molce-42-386]). Numerous bioorthogonal schemes for conjugating chemical probes or tags to target biomolecules have been developed. The most popular schemes that are applicable to selective fluorescence labeling under physiological conditions without interfering with biological systems include copper-catalyzed azide alkyne cycloaddition (CuAAC) ([@b42-molce-42-386]; [@b94-molce-42-386]), photoclick cycloaddition ([@b101-molce-42-386]), strain-promoted azide alkyne cycloaddition (SPAAC) ([@b2-molce-42-386]), and inverse electron-demand Diels--Alder cycloadditions (IEDDA) ([@b9-molce-42-386]; [@b91-molce-42-386]) ([Fig. 2](#f2-molce-42-386){ref-type="fig"}).

CuAAC is a cycloaddition reaction between azide and alkyne groups catalyzed by copper. Because of its rapid (\~3 M^−1^ S^−1^) and highly specific reaction, CuAAC has been applied in numerous contexts ([@b62-molce-42-386]), from organic synthesis to biomolecule conjugation---even in diagnostic and therapeutic settings ([@b34-molce-42-386]). However, despite the speed of the reaction and stability of the conjugation products, cytotoxicity caused by the Cu(l) metal catalyst has remained a lingering concern and has limited the widespread use of CuAAC in certain applications, including live-cell imaging ([@b11-molce-42-386]; [@b19-molce-42-386]). The development of the photoclick cycloaddition scheme, which does not require copper, circumvents this toxicity issue and thus enables the expanded use of CuAAC in living organisms ([@b105-molce-42-386]). One example of such a reaction is photoinducible dipolar cycloaddition, which induces conjugation between an alkene and a nitrile imine, activated from tetrazole ([@b35-molce-42-386]; [@b84-molce-42-386]). Photoclick chemistry offers some additional advantages; the reaction is relatively fast (up to 50 M^−1^ S^−1^) and does not require toxic metals or ligands. Notably, the photo-induced reaction can be controlled in a spatiotemporal manner ([@b53-molce-42-386]). The highly reactive tetrazole group is readily activated by a low-power UV lamp, LED or laser beam, all of which are less harmful to living cells than Cu(I) ([@b77-molce-42-386]).

SPAAC induces bioorthogonal conjugation in the absence of metal catalysts or irradiation by introducing ring strain into an alkyne group ([@b2-molce-42-386]). Many early generation strained alkynes, such as cyclooctyne, exhibited a slow conjugation reaction (\~2 × 10^−3^ M^−1^ S^−1^)---clearly an undesirable attribute. Subsequent studies have improved the stability of the alkyne and reaction rate by modifying the cycloalkyne chemical structure ([@b19-molce-42-386]; [@b25-molce-42-386]). Because of these improvements and inherently low cytotoxicity, SPAAC has come to be broadly used in live mammalian cells ([@b5-molce-42-386]; [@b61-molce-42-386]), and even in animals ([@b5-molce-42-386]; [@b50-molce-42-386]). IEDDA, which enables cycloaddition between a dienophile and a diene, such as 1,2,4,5-tetrazine ([@b9-molce-42-386]; [@b91-molce-42-386]), is a more recently developed bioorthogonal conjugation strategy ([@b7-molce-42-386]). Because of its extremely fast (up to 10^6^ M^−1^ S^−1^) and selective reaction, IEDDA has become a prominent reaction scheme for bioorthogonal conjugation that enables chemical modifications and fluorescent dye labeling of proteins of interest in live mammalian cells ([@b45-molce-42-386]; [@b48-molce-42-386]; [@b67-molce-42-386]).

SITE-SPECIFIC LABELING VIA BIOORTHOGONAL CONJUGATION USING UAAs
===============================================================

CuAAC
-----

Since its first application in a biological system in 2002 ([@b42-molce-42-386]; [@b94-molce-42-386]), the CuAAC approach has been applied to a variety of research areas, including drug development and diagnostics ([@b34-molce-42-386]). However, a practical impediment to its application in living systems is the induction of cytotoxic reactive oxygen species (ROS) by Cu(I) oxidation ([@b11-molce-42-386]). A variety of water-soluble ligands have been designed to reduce the amount of Cu(I) metal catalyst needed to achieve efficient conjugation with minimal cytotoxicity. These include tris-(benzyltriazolylmethyl)amine (TBTA) ([@b15-molce-42-386]), tris-(3-hydroxypropyltriazolylmethyl)-amine (THPTA) ([@b36-molce-42-386]), bis(L-histidine) ([@b39-molce-42-386]), and 2-\[4-{(bis\[(1-tert-butyl-1H-1,2,3-triazol-4-yl)methyl\]amino)methyl}-1H-1,2,3-triazol-1-yl\]acetic acid (BTTAA) ([@b6-molce-42-386]).

To date, several UAA incorporation systems utilizing CuAAC have been successfully applied to label target proteins. For example, the epidermal growth factor receptor (EGFR), a cell surface receptor tyrosine kinase, was visualized in live mammalian cells by site-specifically incorporating the lysine-based UAA, *N*^ε^-*p*-azidobenzyloxycarbonyl lysine (PABK), into the receptor using a PABK-specific synthetase derived from *Methanococcus barkeri* PylRS (MbPylRS). The expressed EGFR bearing PABK was labeled with alkyne-cy5 in the presence of low CuSO~4~ (50 μM) with the help of the ligand BTTAA (300 μM) ([@b19-molce-42-386]). *N*^ɛ^-(propargyloxycarbonyl)-l-lysine, also known as propargyl lysine (PrK), another lysine-based UAA, can be incorporated into proteins using wild-type *Methanococcus mazei* PylRS (MmPylRS) ([@b63-molce-42-386]). PrK has been widely used for bio-conjugation of fluorescent probes in diverse organisms from *E. coli* to mammalian cells ([@b90-molce-42-386]; [@b98-molce-42-386])---even in animals ([@b31-molce-42-386])---because of the simplicity of the synthesis reaction and high incorporation efficiency. With this approach, imaging of target proteins using super resolution microscopy is achievable after PrK-mediated conjugation of probe via a CuAAC scheme and fixation of the cells ([@b98-molce-42-386]). Such a PrK-based labeling scheme has also been applied to hyperspectral stimulated Raman scattering (SRS) microscopy. This study demonstrated labeling of PrK-carrying cellular proteins, such as Sec61β, Htt74Q and the histone H3 variant H3.3, with a sensitive Raman tag by click chemistry for molecular hyperspectral SRS imaging ([@b107-molce-42-386]). However, despite the reliability of UAA incorporation and conjugation reaction, the CuAAC scheme frequently requires a high concentration of CuSO~4~ (\~millimolar levels), which continues to limit its wider application to live-cell imaging ([@b19-molce-42-386]).

Photoclick chemistry
--------------------

The photoactivated 1,3-dipolar cycloaddition reaction between diphenyltetrazole and methyl crotonate in benzene, first reported in 1967 ([@b37-molce-42-386]), has been further expanded to cover nitrile oxide, azomethine ylide, and azide cycloaddition in aqueous media ([@b64-molce-42-386]). 1,3-Dipolar cycloaddition between alkene dipolarophiles and nitrile imine dipoles has also been developed ([@b64-molce-42-386]). Moreover, an efficient photo-inducible bioorthogonal reaction based on photoclick chemistry that enables tetrazole-alkene 1,3-dipolar cycloaddition was recently reported in living cells ([@b105-molce-42-386]).

The lysine-based UAAs, *N*^ε^-(1-methylcycloprop-2-enecarboxamido)-lysine (CpK) and *N*^ɛ^-5-norbornene-2-yloxycarbonyl-L-lysine (NorK), which enable such cycloadditions with photoinduced tetrazole, were designed and co-translationally inserted into proteins by wild-type MbPylRS and a mutant form of MbPylRS carrying five mutations (L266M, L270I, Y271L, L274A, and C313I), respectively ([@b77-molce-42-386]; [@b105-molce-42-386]). The yield of cycloaddition reactions with CpK was higher than that with NorK. Using this system, GFP carrying CpK was expressed and labeled with photoreactive tetrazole by photoirradiation for 2 min with 365 nm UV light ([@b77-molce-42-386]; [@b105-molce-42-386]). Another photoclickable lysine analog, *N*^ε^-acryllysine (AcrK), which requires fewer synthetic steps than CpK, has also been designed. AcrK was co-translationally inserted into target proteins using an engineered MbPylRS bearing six mutations (D76G, L266M, L270I, Y271F, L274A, and C313F). Applying this system to the tubulin-like bacterial cytoskeleton protein, FtsZ, carrying AcrK led to efficient expression and labeling with diaryltetrazole using a 1-minute exposure to 365 nm UV irradiation ([@b53-molce-42-386]).

SPAAC
-----

SPAAC is a simple and spontaneous conjugation between azide and cycloalkyne groups that generates a triazole product without the requirement for a catalyst ([@b2-molce-42-386]). The early stage \[3 + 2\] azide-alkyne cycloaddition using strained cyclooctyne was considerably slower than CuAAC, but various subsequently developed strained alkyne chemical structures have increased the reaction rate ([@b19-molce-42-386]). Thanks to such efforts, SPAAC has been effectively applied to visualize diverse biomolecules, including nucleotides ([@b82-molce-42-386]) and lipids ([@b66-molce-42-386]), in various living systems ([@b3-molce-42-386]). Tetra-acetylated N-azidoacetyl-D-mannosamine (Ac-4ManNAz), an azide-functionalized sugar, can be metabolically incorporated into the cell surface membrane through the sialic acid biosynthetic pathway ([@b5-molce-42-386]; [@b38-molce-42-386]; [@b78-molce-42-386]). The resulting azide-containing glycans can be visualized by labeling with cyclooctyne fluorophores such as difluorinated cyclooctyne (DIFO) ([@b5-molce-42-386]), dibenzocyclooctyne (DIBO) ([@b69-molce-42-386]), azadibenzylcyclooctyne (DIBAC) ([@b23-molce-42-386]) and bicyclo\[6.1.0\]nonyne (BCN) fluorescent dyes, allowing three-dimensional visualization of living melanoma cells ([@b26-molce-42-386]).

The SPAAC scheme has been further expanded to protein molecules in living organisms ([@b72-molce-42-386]). *N*^ε^-(cyclooct-2-yn-1-yloxy)carbonyl)L-lysine (CoK) was site-specifically incorporated into red fluorescent protein mCherry by MmPylRS carrying two mutations, Y306A and Y384F (MmPylRS-AF). mCherry carrying CoK was labeled with coumarin azide and subsequently studied by high-resolution single-molecule Förster resonance energy transfer (FRET) analysis in live *E. coli* cells, illustrating the potential of SPAAC for *in vivo* labeling and visualization of target proteins ([@b72-molce-42-386]). The use of the CoK-based fluorescent tagging scheme was recently extended to labeling intracellular proteins in live mammalian cells ([@b3-molce-42-386]). In this application, alpha tubulin carrying CoK was expressed using mutant MmPylRS-AF and labeled with an azide-bearing, background-free "tame" BODIPY-based probe (AzG-1). Despite such efforts, the application of SPAAC is still limited by its relatively slow conjugation reaction ([@b54-molce-42-386]). To increase reaction rate, researchers have designed diverse cyclooctyne derivatives with enhanced water solubility for labeling of biomolecules in live cells ([@b54-molce-42-386]).

IEDDA
-----

IEDDA is a \[4 + 2\] cycloaddition reaction between 1,2,4,5-tetrazine and dienophiles that is highly specific and extremely fast under physiological conditions ([@b91-molce-42-386]). In addition, it does not require any catalyst or reagent for the conjugation reaction. Because of such favorable characteristics, IEDDA has become one of the most popular bioorthogonal schemes for biological applications. Thus far, a wide range of dienophiles has been designed for IEDDA reactions, and numerous UAAs bearing such dienophile chemical groups have been developed for IEDDA-based bioorthogonal conjugation ([@b70-molce-42-386]; [@b73-molce-42-386]; [@b76-molce-42-386]).

Bicyclo\[6.1.0\]non-4-yn-9-ylmethanol (BCN) is considered an attractive dienophile owing to its excellent reactivity with tetrazine. The BCN-bearing UAA, bicyclo\[6.1.0\]non-4-yn-9-ylmethanol lysine (BCNK), was first designed in 2012 and subsequently genetically incorporated using a mutant form of MbPylRS containing three amino acid substitution (Y271M, L274G, and C313A), generated by directed evolution. This triply mutated MbPylRS exhibited good protein production yield (6--12 mg/L) ([@b49-molce-42-386]). The double mutant, MmPylRS-AF, was also found to incorporate isoforms of BCNK (endo-BCNK and exo-BCNK) with high yield ([@b10-molce-42-386]; [@b67-molce-42-386]; [@b71-molce-42-386]). Exo-BCNK showed higher incorporation efficiency and faster labeling than its isomer when conjugated with monosubstituted tetrazine (H-Tetrazine) fluorophores, which are generally superior to methyl-substituted tetrazine (Me-Tetrazine) moieties ([@b71-molce-42-386]). The BCNK incorporation and tetrazine-based fluorophore conjugation scheme has been successfully applied to label diverse cellular proteins, including cell surface and cytoskeletal proteins.

Trans-cyclooctene (TCO) is a highly reactive dienophile that exhibits about a 10-times higher reaction rate compared with BCN owing to its strained chemical structure ([@b49-molce-42-386]). TCO-bearing lysines (TCOKs) were designed and found to efficiently react with tetrazines. MmPylRS-AF and MbPylRS carrying three mutations (Y271A, L274M, and C313A) were shown to genetically incorporate 2′-TCOK and 4′-TCOK ([@b68-molce-42-386]; [@b71-molce-42-386]). In addition to engineering PylRS, tRNA^pyl^ was also evolved to increase the incorporation of TCOKs and other related bulky UAAs that previously exhibited low incorporation efficiency ([@b80-molce-42-386]). The engineered tRNA, tRNA^M15^, carrying a canonical hinge between the D- and T-loop that is highly conserved in human tRNAs, was found to improve UAA incorporation several fold compared to the original tRNA^pyl^. Combining MbPylRS-AF and the engineered tRNA enabled the extracellular target protein, CRF1R (corticotropin releasing factor type 1 receptor), carrying 2′-TCOK, to be efficiently produced and labeled with cy3-tetrazine dye for *in situ* visualization ([@b80-molce-42-386]).

The efficiency of genetic incorporation and labeling of TCOKs, like BCNKs, is highly dependent on the chemical structure ([@b71-molce-42-386]; [@b96-molce-42-386]). 2′-TCOK showed higher incorporation by MmPylRS-AF and better labeling with tetrazines than 4′-TCOK since it is less reactive towards cysteine residues, which are exposed in many proteins in mammalian cells and might otherwise cause interference ([@b68-molce-42-386]). Moreover, a side-by-side comparison of axial and equatorial isomers of 2′- and 4′-TCOKs showed better labeling efficiency of 2′-aTCOK (axial) and 4′-eTCOK (equatorial) with tetrazines compared with their diastereomers, probably owing to greater chemical stability or a more rapid reaction rate ([@b71-molce-42-386]). This TCOK incorporation and tetrazine-based labeling system has been applied to a wide range of cellular targets, including EGFR ([@b49-molce-42-386]) and actin ([@b71-molce-42-386]). In particular, this scheme was found to be highly useful for visualizing small transmembrane proteins like interferon-inducible transmembrane protein 3 (IFITM3), which could not easily be tracked using the classic fluorescent protein fusion method ([@b71-molce-42-386]).

Background fluorescence resulting from insufficient washing of unreacted probes, which is often caused by the hydrophobicity of UAAs, can be troublesome, especially in visualizing intracellular proteins ([@b43-molce-42-386]). To further improve labeling efficiency of TCOK toward cytosolic proteins, researchers synthesized the more hydrophilic TCOK derivative, dioxo-TCOK (DOTCOK). This UAA was genetically incorporated into proteins by MmPylRS-AF with good yield. Excess DOTCOK is easily removed using considerably shorter washing periods (several minutes) compared with BCNK and TCOK (6 h or longer), which is clearly advantageous for visualizing cytosolic proteins ([@b43-molce-42-386]).

Other useful UAAs that support IEDDA include cyclobutene-containing lysine (CbK) ([@b56-molce-42-386]), norbornene-2-yloxycarbonyl-lysine (NBOK) ([@b48-molce-42-386]), and strained cyclooctyne-lysine (SCOK) ([@b67-molce-42-386]; [@b73-molce-42-386]). CbK is small and chemically stable; it also has a higher conjugation rate with tetrazine than most cycloprene, small alkene or norbornene derivatives, but a lower rate than TCO. CbK was genetically incorporated into OmpX (outer membrane protein X) of *E. coli* using mutant MbPylRS (L274M and C313A) and subsequently labeled with fluorescent tetrazine ([@b56-molce-42-386]). Wild-type MbPylRS efficiently incorporated NBOK with a good production yield of target protein (\~4 mg/L of culture) in *E. coli* and mediated a highly selective cycloaddition reaction with tetrazine *in vitro* ([@b48-molce-42-386]). NBOK also allowed *in vivo* imaging of a membrane-localized target protein using the tetrazine dye, tetramethylrhodamine (TAMRA), although a much longer incubation time (2--16 h) was needed owing to the slow reaction rate (9 M^−1^ S^−1^) ([@b48-molce-42-386]). Notably, SCOK enabled a faster conjugation reaction with tetrazine dye (400 M^−1^ S^−1^) ([@b73-molce-42-386]), and was incorporated by mutant MmPylRS-AF into the insulin receptor (IR) with high yield (10 mg/L of culture) and was efficiently labeled with H-tetrazine dye ([@b67-molce-42-386]).

In addition to lysine analogues, dienophile-carrying tyrosine derivatives have also been utilized. 5-Norbornen-2-ol (NOR), cyclooct-2-ynol (COY), and two isomers of (E)-2-(cyclooct-4-en-1-yloxyl)-ethanol tyrosines (DS1 and DS2) were designed and synthesized. These UAAs were genetically incorporated into target proteins in the outer membrane of *E. coli* using mutant MmPylRS (Y306A, N346A, C348A, and Y384F) and efficiently labeled with fluorescent tetrazine. Among these four dienophiles, cyclooctene-based DS1 and DS2 showed extremely fast conjugation reaction rates (0.6--2.9 × 10^5^ M^−1^ S^−1^) and high labeling efficiency (\~97%). *In vivo* labeling of DS1 and DS2 could be completed within 100 s in the presence of 1 μM fluorescent tetrazine. Collectively, these results demonstrate that genetic UAA incorporation techniques are highly effective in achieving site-specific labeling of cellular target proteins for functional analyses ([@b44-molce-42-386]).

INSPIRING APPLICATIONS AND OUTLOOK
==================================

Beyond its straightforward use for protein labeling and visualization, the UAA-based protein-labeling scheme is beginning to find extended applications in diverse research areas. One of the major drawbacks of the conventional fluorescent protein fusion method is the difficulty in probing component proteins that form higher-order complexes, such as the virus capsid and virus-like particles, owing to their substantial size ([@b20-molce-42-386]). Such difficult target proteins can be accessed and analyzed at the single-molecule level using UAA incorporation and a bioorthogonal probe tagging system ([@b22-molce-42-386]). Influenza hemagglutinin (HA) is a canonical type I viral envelope glycoprotein that is responsible for fusion of the viral envelope with the endosome membrane after entry into host cells. Acidification of the late endosome was thought to trigger a conformational change in HA, although this had not been directly observed. Recombinant influenza HA carrying two 2′-TCOKs (at positions 17 and 127) was produced using MmPylRS-AF and then labeled with Tet-Cy3 and (Me-)Tet-Cy5 via the IEDDA reaction. This dual-labeling scheme made it possible to study the conformational dynamics of single influenza HA molecules triggered by acidification using single-molecule FRET (smFRET) analysis and total internal reflection fluorescence (TIRF) microscopy ([@b22-molce-42-386]) ([Fig. 3A](#f3-molce-42-386){ref-type="fig"}). UAA-based bioorthogonal chemistry can also be applied to analyze differential gene and protein expression. Wild-type methionyl-tRNA synthetase (MetRS) and mutant MetRS^LtoG^ are known to incorporate diverse clickable methionine analogs, including azidohomoalanine (AHA), homopropargylglycine (HPG), and azidonorleucine (ANL), which can be efficiently used for bioorthogonal noncanonical amino acid tagging (BONCAT) technique ([@b24-molce-42-386]; [@b27-molce-42-386]). Proteins carrying Met analogs containing azide or alkyne can be selectively labeled with fluorescence tags for visualization or with affinity tags for enrichment by CuAAC ([Fig. 3B](#f3-molce-42-386){ref-type="fig"}). This method has been used to visualize newly synthesized proteins in diverse organisms, including mouse ([@b13-molce-42-386]) and Drosophila ([@b27-molce-42-386]), in specific contexts, such as viral infection and stress conditions ([@b87-molce-42-386]). This approach also allows spatiotemporal analysis of proteomics after drug treatment or electrophysiological stimulation ([@b92-molce-42-386]). The clear benefit of this technique compared with conventional isotope-based methods is that it confers a higher degree of temporal resolution without the need for isotopes ([@b86-molce-42-386]).

The UAA incorporation technique can be further extended to *in vivo* positron-emission tomography (PET) imaging and pharmacokinetics using pre-targeting components such as antibodies ([@b103-molce-42-386]). An azido-bearing UAA, *N*^ɛ^ -2-azideoethyloxycarbonyl-L-lysine (NEAK), was incorporated into the heavy chain of the anti-CD20 monoclonal antibody, rituximab, using MmPylRS. The heavy chain-carrying NEAK was then linked with bifunctional 4-dibenzocyclooctynol-1,4,7,10-tetraazacyclotetradecane-1,4,7,10-tetraacetic acid (DIBO-DOTA) via copper-free SPAAC. Lastly, the positron-emitting isotope ^64^Cu was chelated to the attached DOTA, generating \[^64^Cu\]-labeled rituximab. Injection of the labeled antibody into mice allowed efficient visualization of CD20-positive tumors by PET imaging for *in vivo* pharmacokinetics studies ([Fig. 3C](#f3-molce-42-386){ref-type="fig"}). These inspiring reports illustrate critical applications of the UAA-based labeling scheme in a wide range of fields, from basic science to clinical research. We are still in the early stages of developing important applications of UAA-based techniques. We anticipate that such imaginative uses of UAA-based strategies will further embolden efforts to investigate complex cellular processes and facilitate more systematic assessments of drug efficacy and pharmacokinetics.
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![Unnatural amino acids used for site-specific protein labeling\
1: 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (Anap), 2: (S)-1-carboxy-3-(7-hydroxy-2-oxo-2H-chromen-4-yl)propan-1-aminium (CouAA), 3: 3-(5-(dimethylamino)naphthalene-1-sulfonamide) propanoic acid (Dansylalanine), 4: *N*^ɛ^-*p*-azidobenzyloxycarbonyl lysine (PABK), 5: Propargyl-L-lysine (PrK), 6: *N*^ɛ^-(1-methylcycloprop-2-enecarboxamido) lysine (CpK), 7: *N*^ɛ^-acryllysine (AcrK), 8: *N*^ɛ^-(cyclooct-2-yn-1-yloxy)carbonyl)L-lysine (CoK), 9: bicyclo\[6.1.0\]non-4-yn-9-ylmethanol lysine (BCNK), 10: trans-cyclooct-2-ene lysine (2′-TCOK), 11: trans-cyclooct-4-ene lysine (4′-TCOK), 12: dioxo-TCO lysine (DOTCOK), 13: 3-(2-cyclobutene-1-yl)propanoic acid (CbK), 14: *N*^ɛ^-5-norbornene-2-yloxycarbonyl-L-lysine (NBOK), 15: cyclooctyne lysine (SCOK), 16: 5-norbornen-2-ol tyrosine (NOR), 17: cyclooct-2-ynol tyrosine (COY), 18: (E)-2-(cyclooct-4-en-1-yloxyl)ethanol tyrosine (DS1/2), 19: azidohomoalanine (AHA), 20: homopropargylglycine (HPG), 21: azidonorleucine (ANL), 22: *N*^ɛ^-2-azideoethyloxycarbonyl-L-lysine (NEAK).](molce-42-386f1){#f1-molce-42-386}

![Bioorthogonal reactions for labeling of a protein of interest\
CuAAC, copper-catalyzed azide alkyne cycloaddition; Photoclick cycloaddition; SPAAC, strain-promoted azide alkyne cycloaddition; IEDDA, inverse electron-demand Diels--Alder cycloadditions.](molce-42-386f2){#f2-molce-42-386}

![Promising applications of UAA-based protein-labeling scheme\
(A) Study of the conformational dynamics of sigle influenza hemagglutinin (HA), (B) high resolution proteomic analysis in diverse organisms, and (C) *in vivo* PET imaging and pharmacokinetics studies.](molce-42-386f3){#f3-molce-42-386}

###### 

Unnatural amino acids and bioorthogonal conjugation schemes

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  UAA                                 Orthogonal AARS    Mutations                                                           Reaction     References
  ----------------------------------- ------------------ ------------------------------------------------------------------- ------------ ----------------------------------------------------------------------------------------------------------
  Fluorescent unnatural amino acids                                                                                                       

   1, Anap                            EcLeuRS            L38F, M40G, L41P, Y499V, Y500L, Y527A, H537E, L538S, F541C, A560V                [@b18-molce-42-386]; [@b51-molce-42-386]

   2, CouAA                           MjTyrRS            Y32E, L65H, A67G, H70G, F108Y, Q109H, D158G, L162G                               [@b16-molce-42-386]; [@b17-molce-42-386]; [@b100-molce-42-386]

   3, Dansylalanine                   EcLeuRS            M40A, L41N, T252A, S497C, Y499I, Y527G, H537T                                    [@b88-molce-42-386]

  Lysine derivatives                                                                                                                      

   4, PABK                            MmPylRS                                                                                CuAAC        [@b19-molce-42-386]

   5, PrK                             MmPylRS                                                                                CuAAC        [@b31-molce-42-386]; [@b63-molce-42-386]; [@b90-molce-42-386]; [@b98-molce-42-386]; [@b107-molce-42-386]

   6, CpK                             MbPylRS                                                                                Photoclick   [@b77-molce-42-386]; [@b105-molce-42-386]

   7, AcrK                            MbPylRS            D76G, L266M, L270I, Y271F, L274A, C313F                             Photoclick   [@b53-molce-42-386]

   8, CoK                             MmPylRS            Y306A, Y384F                                                        SPAAC        [@b3-molce-42-386]; [@b72-molce-42-386]

   9, BCNK                            MbPylRS            Y271M, L274G, C313A                                                 IEDDA        [@b10-molce-42-386]; [@b49-molce-42-386]; [@b67-molce-42-386]; [@b71-molce-42-386]

   10, 2′-TCOK                        MmPylRS, MbPylRS   Y306A, Y384F\                                                       IEDDA        [@b49-molce-42-386]; [@b68-molce-42-386]; [@b71-molce-42-386]
                                                         Y271A, L274M, C313A, respectively.                                               

   11, 4′-TCOK                        MmPylRS, MbPylRS   Y306A, Y384F\                                                       IEDDA        [@b49-molce-42-386]; [@b68-molce-42-386]; [@b71-molce-42-386]
                                                         Y271A, L274M, C313A, respectively.                                               

   12, DOTCOK                         MmPylRS            Y306A, Y384F                                                        IEDDA        [@b43-molce-42-386]

   13, CbK                            MbPylRS            L274M, C313A                                                        IEDDA        [@b56-molce-42-386]

   14, NBOK                           MbPylRS                                                                                IEDDA        [@b48-molce-42-386]

   15, SCOK                           MmPylRS            Y306A, Y384F                                                        IEDDA        [@b67-molce-42-386]; [@b73-molce-42-386]

   22, NEAK                           MmPylRS                                                                                SPAAC        [@b103-molce-42-386]

  Tyrosine derivatives                                                                                                                    

   16, NOR                            MmPylRS            Y306A, N346A, C348A, Y384F                                          IEDDA        [@b44-molce-42-386]

   17, COY                            MmPylRS            Y306A, N346A, C348A, Y384F                                          IEDDA        [@b44-molce-42-386]

   18, DS1/2                          MmPylRS            Y306A, N346A, C348A, Y384F                                          IEDDA        [@b44-molce-42-386]

  Methionine analogs                                                                                                                      

   19, AHA                            MetRS                                                                                               [@b13-molce-42-386]; [@b24-molce-42-386]; [@b86-molce-42-386]; [@b92-molce-42-386]

   20, HPG                            MetRS                                                                                               [@b13-molce-42-386]; [@b86-molce-42-386]; [@b87-molce-42-386]; [@b92-molce-42-386]

   21, ANL                            MetRS              L13G                                                                             [@b27-molce-42-386]; [@b86-molce-42-386]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: Present address: CHA Advanced Research Institute, Seongnam 13488, Korea
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